S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
Log in
NASDAQ:UG

United-Guardian Stock Forecast, Price & News

$14.17
-0.03 (-0.21 %)
(As of 01/15/2021 08:00 PM ET)
Add
Compare
Today's Range
$14.17
Now: $14.17
$14.17
50-Day Range
$14.14
MA: $14.44
$15.35
52-Week Range
$10.65
Now: $14.17
$20.05
Volume20,800 shs
Average Volume5,634 shs
Market Capitalization$65.04 million
P/E Ratio15.74
Dividend Yield5.03%
Beta0.02
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products in the United States and internationally. It offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL PF and NORGEL, a preservative-free form of LUBRAJEL; LUBRAJEL NATURAL, which are natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; LUBRASLIDE and B-122 powdered lubricants that are used in the manufacture of pressed powders, eyeliners, and rouges; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. The company's medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. Its pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder. The company's industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based cleanser. It also conducts research and development, primarily related to the development of cosmetic ingredients. The company markets its products through marketing partners, distributors, and wholesalers. United-Guardian, Inc. was founded in 1942 and is headquartered in Hauppauge, New York.

MarketRank

Overall MarketRank

1.02 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Toilet preparations
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone(631) 273-0900
Employees23

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$13.60 million
Cash Flow$1.06 per share
Book Value$2.31 per share

Profitability

Net Income$4.76 million

Miscellaneous

Market Cap$65.04 million
Next Earnings Date3/18/2021 (Estimated)
OptionableNot Optionable
$14.17
-0.03 (-0.21 %)
(As of 01/15/2021 08:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive UG News and Ratings via Email

Sign-up to receive the latest news and ratings for UG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











United-Guardian (NASDAQ:UG) Frequently Asked Questions

How has United-Guardian's stock been impacted by Coronavirus (COVID-19)?

United-Guardian's stock was trading at $15.20 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, UG stock has decreased by 6.8% and is now trading at $14.17.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than United-Guardian?

Wall Street analysts have given United-Guardian a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but United-Guardian wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is United-Guardian's next earnings date?

United-Guardian is scheduled to release its next quarterly earnings announcement on Thursday, March 18th 2021.
View our earnings forecast for United-Guardian
.

How were United-Guardian's earnings last quarter?

United-Guardian, Inc. (NASDAQ:UG) announced its quarterly earnings results on Tuesday, November, 10th. The company reported $0.16 EPS for the quarter. The business had revenue of $2.34 million for the quarter. United-Guardian had a return on equity of 37.02% and a net margin of 32.85%.
View United-Guardian's earnings history
.

How often does United-Guardian pay dividends? What is the dividend yield for United-Guardian?

United-Guardian declared a semi-annual dividend on Monday, November 23rd. Shareholders of record on Tuesday, December 1st will be paid a dividend of $0.36 per share on Tuesday, December 8th. This represents a yield of 4.9%. The ex-dividend date of this dividend is Monday, November 30th.
View United-Guardian's dividend history
.

Is United-Guardian a good dividend stock?

United-Guardian pays an annual dividend of $0.72 per share and currently has a dividend yield of 5.03%. UG has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
View United-Guardian's dividend history.

Are investors shorting United-Guardian?

United-Guardian saw a decline in short interest in December. As of December 31st, there was short interest totaling 900 shares, a decline of 64.0% from the December 15th total of 2,500 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ∞ days.
View United-Guardian's Short Interest
.

Who are some of United-Guardian's key competitors?

What other stocks do shareholders of United-Guardian own?

Based on aggregate information from My MarketBeat watchlists, some companies that other United-Guardian investors own include Marathon Petroleum (MPC), Pfizer (PFE), AT&T (T), Teekay LNG Partners (TGP), Verizon Communications (VZ), Walgreens Boots Alliance (WBA), Wells Fargo & Company (WFC), Continental Resources (CLR), Cinemark (CNK) and Dominion Energy (D).

Who are United-Guardian's key executives?

United-Guardian's management team includes the following people:
  • Mr. Kenneth H. Globus, Pres, Gen. Counsel, CEO & Chairman (Age 68, Pay $438.79k)
  • Ms. Andrea J. Young, CFO, Treasurer, Controller & Sec. (Age 51, Pay $124.21k)
  • Mr. Peter A. Hiltunen, Sr. VP (Age 61, Pay $216.25k)
  • Ms. Donna Vigilante, VP, R&D Mang. and Director of Technical Services

What is United-Guardian's stock symbol?

United-Guardian trades on the NASDAQ under the ticker symbol "UG."

How do I buy shares of United-Guardian?

Shares of UG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is United-Guardian's stock price today?

One share of UG stock can currently be purchased for approximately $14.17.

How big of a company is United-Guardian?

United-Guardian has a market capitalization of $65.04 million and generates $13.60 million in revenue each year. United-Guardian employs 23 workers across the globe.

What is United-Guardian's official website?

The official website for United-Guardian is www.u-g.com.

How can I contact United-Guardian?

United-Guardian's mailing address is 230 MARCUS BOULEVARD, HAUPPAUGE NY, 11788. The company can be reached via phone at (631) 273-0900.

This page was last updated on 1/19/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.